Latest News about PFE
Recent news which mentions PFE
Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
October 09, 2024
Tickers
PFE
From Motley Fool
Tickers
PFE
From Motley Fool
Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report
October 08, 2024
From Benzinga
Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated
October 07, 2024
From Benzinga
Pfizer Stock Is Moving Higher Monday: What's Driving The Action?
October 07, 2024
From Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
October 07, 2024
From Benzinga
From Benzinga
From Benzinga
Amid Pfizer's Struggles With Declining Demand For COVID-19 Treatments, Activist Investor Starboard Value Invests $1B In Pharma Giant: Report
October 06, 2024
From Benzinga
3 High-Yield Dividend Stocks That Are Screaming Buys Right Now
October 06, 2024
From Motley Fool
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
From Motley Fool
From Motley Fool
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
From Motley Fool
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
October 03, 2024
From Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
October 02, 2024
From Benzinga
3 Sensational Ultrahigh-Yield Dividend Stocks That Make for No-Brainer Buys in the 4th Quarter (and Beyond)
October 02, 2024
From Motley Fool
Tickers
PFE
From Motley Fool
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
From Benzinga
The Covid Era Tech Promises To Reinvent Cancer Treatment
October 01, 2024
From Benzinga
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
October 01, 2024
From Benzinga
Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
September 30, 2024
From Benzinga
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
September 30, 2024
From Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
September 28, 2024
From Motley Fool
Pfizer Voluntarily Withdraws Sickle Cell Disease Treatment Oxbryta From Global Market Due To Painful Disease Complication, Deaths
September 26, 2024
From Benzinga
2 High-Yield Dividend Stocks That Can Deliver a Lifetime of Passive Income
September 26, 2024
From Motley Fool
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
September 26, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.